Clinical Trial Update: Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration

View source ↗

Summary

A completed clinical trial evaluated the effects of aflibercept on human corneal endothelial cells in neovascular age-related macular degeneration. The study ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Ulucanlar Eye Training and Research Hospital | Conditions: Age Related Macular Degeneration | Status: COMPLETED